Next report date
≈
July 24
Report period
Q1 2025
EPS estimate
—
Revenue estimate
—
30.35 INR
673.42 M INR
3.44 B INR
19.28 M
About VIMTA LABS LTD
Sector
CEO
Harita Vasireddi
Website
Headquarters
Hyderabad
Founded
1984
ISIN
INE579C01029
FIGI
BBG000D1WX95
Vimta Labs Ltd. engages in the provision of contract research and testing. It services include cGMP laboratory services; analytical food and water; preclinical research; clinical research; biopharma; environmental assessments; and clinical reference lab. The company was founded by Sivalinga Prasad Vasireddi in 1984 and is headquartered in Hyderabad, India.
15.0%
16.3%
17.6%
18.9%
20.2%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
250.00 M
500.00 M
750.00 M
1.00 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
250.00 M
500.00 M
750.00 M
1.00 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
250.00 M
500.00 M
750.00 M
1.00 B
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
90.00 M
180.00 M
270.00 M
360.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
Vimta Labs trying to be victorious.Vimta Labs Ltd. engages in the provision of contract research and testing. It services include cGMP laboratory services; analytical food and water; preclinical research; clinical research; biopharma; environmental assessments; and clinical reference lab.
Vimta Labs Ltd. CMP is 558.20. The positive
Darvas Box Strategy - Breakout StockDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only.
Stock has given break out. Buy above high. Keep this stock in watch list.
Buy above the High and do not forget to keep stop lo
#vimtalabs #ipcalab #lauruslabs #lalpathlab #guficbio #alkem#VIMTALABS
NSE: VIMTALABS
CMP: 461
TP: 560
SL: 410
TF: <6m
RR > 2 times
Return > 22%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BU
pe i just 19 while industry pe is 97. available at cheapVimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.
Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VIMTALABS is 1,030.00 INR — it has increased by 1.33% in the past 24 hours. Watch VIMTA LABS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange VIMTA LABS LTD stocks are traded under the ticker VIMTALABS.
VIMTALABS stock has fallen by −1.98% compared to the previous week, the month change is a 13.32% rise, over the last year VIMTA LABS LTD has showed a 115.04% increase.
VIMTALABS reached its all-time high on Feb 12, 2025 with the price of 1,178.00 INR, and its all-time low was 12.55 INR and was reached on Mar 13, 2009. View more price dynamics on VIMTALABS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VIMTALABS stock is 5.34% volatile and has beta coefficient of 1.02. Track VIMTA LABS LTD stock price on the chart and check out the list of the most volatile stocks — is VIMTA LABS LTD there?
Today VIMTA LABS LTD has the market capitalization of 21.82 B, it has decreased by −0.83% over the last week.
Yes, you can track VIMTA LABS LTD financials in yearly and quarterly reports right on TradingView.
VIMTA LABS LTD is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
VIMTALABS net income for the last quarter is 183.19 M INR, while the quarter before that showed 214.96 M INR of net income which accounts for −14.78% change. Track more VIMTA LABS LTD financial stats to get the full picture.
Yes, VIMTALABS dividends are paid annually. The last dividend per share was 2.00 INR. As of today, Dividend Yield (TTM)% is 0.20%. Tracking VIMTA LABS LTD dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIMTA LABS LTD EBITDA is 1.21 B INR, and current EBITDA margin is 35.45%. See more stats in VIMTA LABS LTD financial statements.
Like other stocks, VIMTALABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIMTA LABS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIMTA LABS LTD technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIMTA LABS LTD stock shows the buy signal. See more of VIMTA LABS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.